115 related articles for article (PubMed ID: 20874016)
1. Nanopharmacology of liposomes developed for cancer therapy.
Muthu MS; Feng SS
Nanomedicine (Lond); 2010 Sep; 5(7):1017-9. PubMed ID: 20874016
[No Abstract] [Full Text] [Related]
2. Surface-active liposomes for targeted cancer therapy.
Sofou S
Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
[TBL] [Abstract][Full Text] [Related]
3. Liposomal nanomedicine for breast cancer therapy.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
Nanomedicine (Lond); 2011 Aug; 6(6):1085-100. PubMed ID: 21955078
[TBL] [Abstract][Full Text] [Related]
4. Targeting liposomes toward novel pediatric anticancer therapeutics.
Federman N; Denny CT
Pediatr Res; 2010 May; 67(5):514-9. PubMed ID: 20118828
[TBL] [Abstract][Full Text] [Related]
5. Liposomes and cancer therapy.
Gregoriadis G; Florence AT
Cancer Cells; 1991 Apr; 3(4):144-6. PubMed ID: 1883687
[No Abstract] [Full Text] [Related]
6. Enhanced bacterial cancer therapy with hydroxychloroquine liposomes.
Park K
J Control Release; 2018 Jun; 280():124. PubMed ID: 29880282
[No Abstract] [Full Text] [Related]
7. Emerging patents for cancer-targeted nanomedicines.
Muthu MS; Pandey BL; Sahu AK; Rajesh CV
Pharm Pat Anal; 2012 May; 1(2):113-5. PubMed ID: 24236774
[No Abstract] [Full Text] [Related]
8. [Means of increasing the effectiveness of drug therapy of malignant neoplasms].
Borisov VI; Rusakov IG; Bogdanova NV
Sov Med; 1986; (6):53-8. PubMed ID: 3529449
[No Abstract] [Full Text] [Related]
9. Drug delivery in cancer using liposomes.
Dass CR
Methods Mol Biol; 2008; 437():177-82. PubMed ID: 18369969
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine in cancer treatment.
Yih TC; Wei C
Nanomedicine; 2005 Jun; 1(2):191-2. PubMed ID: 17292078
[No Abstract] [Full Text] [Related]
11. Nanomedicine transforms drug delivery.
Shaffer C
Drug Discov Today; 2005 Dec; 10(23-24):1581-2. PubMed ID: 16376810
[No Abstract] [Full Text] [Related]
12. Lipid-enveloped hybrid nanoparticles for drug delivery.
Tan S; Li X; Guo Y; Zhang Z
Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
[TBL] [Abstract][Full Text] [Related]
13. Liposomal drug formulations in cancer therapy: 15 years along the road.
Slingerland M; Guchelaar HJ; Gelderblom H
Drug Discov Today; 2012 Feb; 17(3-4):160-6. PubMed ID: 21983329
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine for multimodality treatment of cancer.
Mi Y; Guo Y; Feng SS
Nanomedicine (Lond); 2012 Dec; 7(12):1791-4. PubMed ID: 23249329
[No Abstract] [Full Text] [Related]
15. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
Taurin S; Nehoff H; Greish K
J Control Release; 2012 Dec; 164(3):265-75. PubMed ID: 22800576
[TBL] [Abstract][Full Text] [Related]
16. EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy.
Maeda H; Matsumura Y
Adv Drug Deliv Rev; 2011 Mar; 63(3):129-30. PubMed ID: 20457195
[No Abstract] [Full Text] [Related]
17. Nanomedicine and drug delivery.
Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
[TBL] [Abstract][Full Text] [Related]
18. Liposomes for drug targeting in cancer chemotherapy.
Liliemark J
Eur J Surg Suppl; 1991 May; (561):49-52. PubMed ID: 1720049
[No Abstract] [Full Text] [Related]
19. Nanoparticle technologies for cancer therapy.
Alexis F; Pridgen EM; Langer R; Farokhzad OC
Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
[TBL] [Abstract][Full Text] [Related]
20. Targeted drug delivery.
Leyland-Jones B
Semin Oncol; 1993 Feb; 20(1):12-7. PubMed ID: 8475405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
